Skip to main content
Erschienen in: Heart and Vessels 2/2012

01.03.2012 | Original Article

Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry

verfasst von: Mariano Valdés Chavarri, Armando Bethencourt, Eduardo Pinar, Alfredo Gomez, Javier Fernández Portales, Francisco Pomar, Isabel Calvo, Jose Ramón López Minguez, Raúl Valdesuso, José Moreu, Antonio Martínez, Wail Nammas

Erschienen in: Heart and Vessels | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

We sought to explore the immediate clinical and angiographic results of the Titan® stent implantation in diabetic patients, as well as the major adverse cardiac events (MACE) at 6-month follow-up. We enrolled 156 consecutive diabetic patients admitted to undergo percutaneous intervention for at least one significant (50%) coronary lesion. All lesions were treated with the Titan® stent implantation according to the contemporary interventional techniques. Patients were prospectively followed-up for at least 6 months. The primary endpoint was MACE at 6-month follow-up [cardiac death, myocardial infarction (MI), or target lesion revascularization (TLR)]. Secondary endpoints included angiographic and clinical procedural success, in-hospital MACE, TLR at 6-month follow-up, and stent thrombosis. The mean age was 66.7 ± 9.6 years, (68.4% males). A total of 197 Titan® stents were implanted in 163 lesions. Direct stenting was performed in 45.2% of the cases. The mean stent diameter was 3.1 ± 0.61 mm, and the mean length was 18.0 ± 8.9 mm. Average stent deployment pressure was 13.9 ± 4.2 bars. Angiographic procedural success was achieved in 154 (98.7%) cases, and clinical procedural success was achieved in 153 (98.1%) cases. One patient developed in-hospital non-Q-wave MI following the procedure. Clinical follow-up was completed in 155 (99.4%) patients. Three patients (1.9%) died of a cardiac or unknown cause, and two (1.3%) developed MI. TLR was performed in 11 patients (7.1%). Cumulative MACE at 6-month follow-up occurred in 16 (10.3%) patients. No patient suffered stent thrombosis. Titan® stent implantation in diabetic patients achieves an excellent immediate clinical and angiographic outcome, with a low incidence of MACE at mid-term follow-up.
Literatur
1.
Zurück zum Zitat Taubert G, Winkelmann BR, Schleiffer T, März W, Winkler R, Gök R, Klein B, Schneider S, Boehm BO (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3,266 patients scheduled for coronary angiography. Am Heart J 145:285–291PubMedCrossRef Taubert G, Winkelmann BR, Schleiffer T, März W, Winkler R, Gök R, Klein B, Schneider S, Boehm BO (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3,266 patients scheduled for coronary angiography. Am Heart J 145:285–291PubMedCrossRef
2.
Zurück zum Zitat Church TS, La Monte MJ, Barlow CE, Blair SN (2005) Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 165:2114–2120PubMedCrossRef Church TS, La Monte MJ, Barlow CE, Blair SN (2005) Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 165:2114–2120PubMedCrossRef
3.
Zurück zum Zitat Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002) Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637–2641PubMedCrossRef Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002) Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637–2641PubMedCrossRef
4.
Zurück zum Zitat Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB 3rd (1995) Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979–989PubMed Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB 3rd (1995) Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979–989PubMed
5.
Zurück zum Zitat Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N, Feit F, Wolski K, Bittl JA, Wilcox R, Topol EJ, Lincoff AM (2005) Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 Trial. J Am Coll Cardiol 45:1932–1938PubMedCrossRef Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N, Feit F, Wolski K, Bittl JA, Wilcox R, Topol EJ, Lincoff AM (2005) Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 Trial. J Am Coll Cardiol 45:1932–1938PubMedCrossRef
6.
Zurück zum Zitat Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S (1994) A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501PubMedCrossRef Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S (1994) A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501PubMedCrossRef
7.
Zurück zum Zitat Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M (1994) A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489–495PubMedCrossRef Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M (1994) A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489–495PubMedCrossRef
8.
Zurück zum Zitat Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB (1999) Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 33:1610–1618PubMedCrossRef Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB (1999) Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 33:1610–1618PubMedCrossRef
9.
10.
Zurück zum Zitat Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32:584–589PubMedCrossRef Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32:584–589PubMedCrossRef
11.
Zurück zum Zitat Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE (2008) Impact of drug-eluting stents among insulin-treated diabetic patients. A report from the NHLBI Dynamic Registry. JACC Cardiovasc Interv 1:139–147PubMedCrossRef Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE (2008) Impact of drug-eluting stents among insulin-treated diabetic patients. A report from the NHLBI Dynamic Registry. JACC Cardiovasc Interv 1:139–147PubMedCrossRef
12.
Zurück zum Zitat Nordmann AJ, Briel M, Bucher HC (2006) Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27:2784–2814PubMedCrossRef Nordmann AJ, Briel M, Bucher HC (2006) Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27:2784–2814PubMedCrossRef
13.
Zurück zum Zitat Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first generation drug-eluting stents: a cause for concern. Circulation 115:1440–1455PubMedCrossRef Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first generation drug-eluting stents: a cause for concern. Circulation 115:1440–1455PubMedCrossRef
14.
Zurück zum Zitat Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, SCAAR Study Group (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009–1019PubMedCrossRef Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, SCAAR Study Group (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009–1019PubMedCrossRef
15.
Zurück zum Zitat Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G, EVASTENT Investigators (2007) Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT matched-cohort registry. J Am Coll Cardiol 50:501–508PubMedCrossRef Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G, EVASTENT Investigators (2007) Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT matched-cohort registry. J Am Coll Cardiol 50:501–508PubMedCrossRef
16.
Zurück zum Zitat Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tüller D, Zbinden R, Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM (2005) Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation 111:2617–2622PubMedCrossRef Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tüller D, Zbinden R, Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM (2005) Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation 111:2617–2622PubMedCrossRef
17.
Zurück zum Zitat Karjalainen PP, Ylitalo A, Airaksinen KE (2006) Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry. Eurointervention 2:187–191PubMed Karjalainen PP, Ylitalo A, Airaksinen KE (2006) Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry. Eurointervention 2:187–191PubMed
18.
Zurück zum Zitat Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Jefary J, Guetta V, Solomon M, Lotan C (2006) The titanium-NO stent: results of a multicenter registry. Eurointervention 2:192–196PubMed Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Jefary J, Guetta V, Solomon M, Lotan C (2006) The titanium-NO stent: results of a multicenter registry. Eurointervention 2:192–196PubMed
19.
Zurück zum Zitat Mosseri M, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Miller H, Jafari J, Guetta V, Solomon M, Lotan C (2005) Short and long term outcome of the titanium-NO stent registry. Cardiovasc Revasc Med 6:2–6PubMedCrossRef Mosseri M, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Miller H, Jafari J, Guetta V, Solomon M, Lotan C (2005) Short and long term outcome of the titanium-NO stent registry. Cardiovasc Revasc Med 6:2–6PubMedCrossRef
20.
Zurück zum Zitat Giraud-Sauveur Y (2007) Titan 2 bio-active stent (BAS) with titanium-NO. Eurointervention 3:526–528CrossRef Giraud-Sauveur Y (2007) Titan 2 bio-active stent (BAS) with titanium-NO. Eurointervention 3:526–528CrossRef
21.
Zurück zum Zitat Karjalainen PP, Ylitalo A, Airaksinen JK (2006) Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol 18:462–468PubMed Karjalainen PP, Ylitalo A, Airaksinen JK (2006) Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol 18:462–468PubMed
22.
Zurück zum Zitat Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE (2010) Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol 144:42–46PubMedCrossRef Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE (2010) Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol 144:42–46PubMedCrossRef
23.
Zurück zum Zitat Karjalainen PP, Ylitalo A, Niemelä M, Kervinen K, Mäkikallio T, Pietili M, Sia J, Tuomainen P, Nyman K, Airaksinen KE (2008) Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. Eurointervention 4:234–241PubMedCrossRef Karjalainen PP, Ylitalo A, Niemelä M, Kervinen K, Mäkikallio T, Pietili M, Sia J, Tuomainen P, Nyman K, Airaksinen KE (2008) Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. Eurointervention 4:234–241PubMedCrossRef
24.
Zurück zum Zitat Karjalainen PP, Ylitalo A, Niemela M, Kervinen K, Makikallio T, Pietila M, Sia J, Tuomainen P, Nyman K, Airaksinen KE (2009) Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med 41:599–607PubMedCrossRef Karjalainen PP, Ylitalo A, Niemela M, Kervinen K, Makikallio T, Pietila M, Sia J, Tuomainen P, Nyman K, Airaksinen KE (2009) Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med 41:599–607PubMedCrossRef
25.
Zurück zum Zitat The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5–S20 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5–S20
26.
Zurück zum Zitat Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O’Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47:e1–e121PubMedCrossRef Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O’Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47:e1–e121PubMedCrossRef
27.
Zurück zum Zitat Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef
28.
Zurück zum Zitat Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231PubMedCrossRef Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231PubMedCrossRef
29.
Zurück zum Zitat Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ (2004) A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 364:583–591PubMedCrossRef Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ (2004) A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 364:583–591PubMedCrossRef
30.
Zurück zum Zitat Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, RAVEL Study Group (2002) Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRef Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, RAVEL Study Group (2002) Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRef
31.
Zurück zum Zitat Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113:2803–2809PubMedCrossRef Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113:2803–2809PubMedCrossRef
32.
Zurück zum Zitat Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130PubMedCrossRef Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130PubMedCrossRef
34.
Zurück zum Zitat Hung-I Y, Shao-Kou L, Tin-Yi T, Ray-Ching H, Wun-Hsing L, Cheng-Ho T (2006) Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A 76:835–841 Hung-I Y, Shao-Kou L, Tin-Yi T, Ray-Ching H, Wun-Hsing L, Cheng-Ho T (2006) Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A 76:835–841
35.
Zurück zum Zitat Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW (2004) Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109:2273–2278PubMedCrossRef Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW (2004) Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109:2273–2278PubMedCrossRef
36.
Zurück zum Zitat Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME, BASKET Investigators (2005) Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 366:921–929PubMedCrossRef Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME, BASKET Investigators (2005) Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 366:921–929PubMedCrossRef
37.
Zurück zum Zitat Ari H, Ari S, Erdoğan E, Tiryakioğlu O, Ustündağ Y, Huysal K, Koca V, Bozat T (2010) A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine. Heart Vessels 25:19–26PubMedCrossRef Ari H, Ari S, Erdoğan E, Tiryakioğlu O, Ustündağ Y, Huysal K, Koca V, Bozat T (2010) A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine. Heart Vessels 25:19–26PubMedCrossRef
38.
Zurück zum Zitat Cirillo P, De Rosa S, Di Palma V, De Rosa R, Maietta P, Piscione F, Chiariello M (2009) Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. Heart Vessels 24:313–316PubMedCrossRef Cirillo P, De Rosa S, Di Palma V, De Rosa R, Maietta P, Piscione F, Chiariello M (2009) Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. Heart Vessels 24:313–316PubMedCrossRef
Metadaten
Titel
Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry
verfasst von
Mariano Valdés Chavarri
Armando Bethencourt
Eduardo Pinar
Alfredo Gomez
Javier Fernández Portales
Francisco Pomar
Isabel Calvo
Jose Ramón López Minguez
Raúl Valdesuso
José Moreu
Antonio Martínez
Wail Nammas
Publikationsdatum
01.03.2012
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2012
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-011-0136-2

Weitere Artikel der Ausgabe 2/2012

Heart and Vessels 2/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.